KEAP1 and viral infectious disease: The new approach to influencing intracellular protein–protein interactions demonstrated on the example of the Keap1-Nrf2 system can be further applied to the treatment of a very wide range of different diseases, directly associated with oxidative stress in cells or indirectly, like viral infections, including that of SARS-CoV-2 [5].